Journal
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM
Volume 3, Issue 10, Pages 696-704Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncpendmet0616
Keywords
metabolic syndrome; obesity; pregnancy; polycystic ovary syndrome; women
Categories
Funding
- NCRR NIH HHS [K23 RR023333-01A1, K23 RR023333] Funding Source: Medline
- NIMHD NIH HHS [L32 MD001077, L32 MD001077-02] Funding Source: Medline
Ask authors/readers for more resources
The metabolic syndrome is estimated to be present in 47 million US residents with a similar age-adjusted prevalence in men (24%) and women (23%). The consideration of various metabolic risk factors as a single entity in the metabolic syndrome provides clinicians with a tool by which they can identify a population at increased risk for type 2 diabetes mellitus and increased cardiovascular morbidity and mortality. Cardiovascular disease is the leading cause of mortality in women in the US. To reduce the risk of cardiovascular disease, efforts have focused on modifying the metabolic risk factors that constitute the metabolic syndrome: abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. In addition, because of several circumstances specific to women, including pregnancy, polycystic ovary syndrome, oral contraceptive therapy use, and menopause, there are special considerations regarding risk factor identification, modification, and clinical management. This article provides a review of diagnostic and therapeutic issues that clinicians should consider when caring for women at risk for developing or diagnosed with the metabolic syndrome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available